A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
The aim of the study is to evaluate the efficacy and safety of tralokinumab in adults with atopic dermatitis
Inclusion Criteria:
Exclusion Criteria:
Shibuya-ku, 150-0034, Japan
Shinjuku-ku, 160-0004, Japan
Shinjuku-ku, 160-0023, Japan
Shinjuku-ku, 169-0075, Japan